NCT02800473View on ClinicalTrials.gov

Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 4, 2016

Primary Completion Date

October 4, 2017

Study Completion Date

October 6, 2017

Conditions
Bladder Cancer
Interventions
DEVICE

Strorz (commercial)

DEVICE

CyPaM2 (experimental)

Trial Locations (1)

54519

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02800473 - Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection | Biotech Hunter | Biotech Hunter